ACTIVE

ACT-WISE

Export PDF
Financial year 2026 · closed on 31/03/2026
Net result
131 k €
+11.9% YoY
Gross margin
474 k €
-2.5% YoY
Equity
217,8 k €
+0.0% YoY
Workforce
4,7 ETP
-11.3% YoY

What does ACT-WISE do?

ACT-WISE is a Private limited company incorporated in 2008. Its main activity is: Organisation of conventions and trade shows. Its registered office is in Gent. It employs on average 4,7 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0895.327.519
Incorporation
30/01/2008
Legal form
Private limited company
Registered office
Tentoonstellingslaan 134
9000 Gent · FlandreSee on map
Contributed capital
50 000,00 €
Latest accounts
31/03/2026
Average workforce
4,7 ETP
Activities (NACE)
82300Organisation of conventions and trade shows· main82300Organisation of conventions and trade shows70210Public relations and communication activities73300Advertising and market research93299Other amusement and recreation activities93299Other amusement and recreation activities
Joint committees (1)
  • 218
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 14 financial years

20262025202420232022202120202019201820172016201520142013
Income statement
Gross margin474 k €485,9 k €696,6 k €650,8 k €243,2 k €166,8 k €406,6 k €333 k €229,8 k €251,7 k €199,8 k €296,8 k €159,7 k €125,5 k €
EBITDA145,9 k €129,4 k €132,3 k €371,4 k €66,7 k €68,4 k €139 k €119,9 k €56,5 k €84,9 k €44,5 k €159,2 k €85 k €71,7 k €
Operating result135,2 k €120,9 k €124,6 k €367,5 k €64,2 k €62,6 k €132,6 k €112,6 k €50,7 k €79,5 k €29 k €142,7 k €68,4 k €59,1 k €
Net result131 k €117,1 k €69,1 k €364,8 k €58,2 k €54,7 k €127,4 k €106,4 k €28,1 k €44,4 k €1,7 k €91,5 k €59,8 k €40,7 k €
Balance sheet
Equity217,8 k €217,7 k €217,6 k €245,5 k €329,6 k €296,4 k €313,2 k €310,8 k €304,4 k €276,3 k €231,9 k €230,3 k €158,8 k €114 k €
Total assets1,1 M €1,3 M €1,5 M €2,3 M €1,7 M €684,3 k €1,6 M €1,1 M €1,5 M €1,1 M €1 M €1,1 M €978,2 k €747,5 k €
Cash372,4 k €583,6 k €480,3 k €683,7 k €625,7 k €514,3 k €880,9 k €555,3 k €329,9 k €373,5 k €215,3 k €226,1 k €400,5 k €182,3 k €
Debts156,8 k €150,6 k €140,6 k €431,2 k €78,7 k €124,4 k €155,3 k €130,8 k €29,3 k €37,8 k €280,9 k €256,7 k €147,6 k €19,3 k €
Other
Workforce4,7 ETP5,3 ETP6,8 ETP5,0 ETP3,8 ETP4,2 ETP4,9 ETP4,5 ETP4,8 ETP3,9 ETP4,0 ETP3,5 ETP2,5 ETP1,5 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2026 · 2 active · 7 ended

Active mandates

BELIEPHARMA

bestuurder · 0457.655.502

Represented by Mark De Belie

Active
De Prins Smiling

bestuurder · 1002.337.325

Represented by Freya De Prins

Active

Ended mandates

BELIEPHARMA

bestuurder · 0457.655.502

Represented by Mark De Belie

Ended
BELIEPHARMA

Director · 0457.655.502

Represented by Mark De Belie

Ended
BELIEPHARMA

Manager · 0457.655.502

Represented by Mark De Belie

Ended
Christophe Van Campenhout

Manager

Ended
Annual accounts

Full financial information

202620252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202501/04/202401/04/202301/04/202201/04/202101/04/2020
Closing of the financial year31/03/202631/03/202531/03/202431/03/202331/03/202231/03/2021
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/09/202628/08/202529/10/202430/10/202331/10/202227/08/2021
General meeting04/09/202627/08/202516/09/202418/09/202319/09/202226/08/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

18 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/03/202604/09/202608/09/2026DutchPDF
Abridged model31/03/202527/08/202528/08/2025DutchPDF
Abridged model31/03/202416/09/202429/10/2024DutchPDF
Abridged model31/03/202318/09/202330/10/2023DutchPDF
Abridged model31/03/202219/09/202231/10/2022DutchPDF
Abridged model31/03/202126/08/202127/08/2021DutchPDF
Abridged model31/03/202024/08/202025/08/2020DutchPDF
Abridged model31/03/201922/07/201923/07/2019DutchPDF
Abridged model31/03/201823/07/201819/09/2018DutchPDF
Abridged model31/03/201711/09/201711/09/2017DutchPDF
Abridged model31/03/201619/09/201623/09/2016DutchPDF
Abridged model31/03/201521/09/201527/10/2015DutchPDF
Abridged model31/03/201415/09/201409/10/2014DutchPDF
Abridged model31/03/201316/09/201322/10/2013DutchPDF
Abridged model31/03/201217/09/201222/10/2012DutchPDF
Abridged model31/03/201119/09/201112/10/2011DutchPDF
Abridged model31/03/201020/09/201029/09/2010DutchPDF
Abridged model31/03/200921/09/200924/09/2009DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2026 · 2 active · 7 ended

Active mandates

BELIEPHARMA

bestuurder · 0457.655.502

Represented by Mark De Belie

Active
De Prins Smiling

bestuurder · 1002.337.325

Represented by Freya De Prins

Active

Ended mandates

BELIEPHARMA

bestuurder · 0457.655.502

Represented by Mark De Belie

Ended
BELIEPHARMA

Director · 0457.655.502

Represented by Mark De Belie

Ended
BELIEPHARMA

Manager · 0457.655.502

Represented by Mark De Belie

Ended
Christophe Van Campenhout

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates30/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/12/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/09/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office30/12/2011
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Registered office05/03/2010
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Registered office12/12/2008
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other08/02/2008
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 2026131 k €↑
  2. 2025
    Annual accounts 2025117,1 k €↑
  3. 2024
    Annual accounts 202469,1 k €↓
  4. 2023
    Annual accounts 2023364,8 k €↑
  5. 2022
    Annual accounts 202258,2 k €↑
  6. 2021
    Annual accounts 202154,7 k €↓
  7. 2020
    Annual accounts 2020127,4 k €↑
  8. 2019
    Annual accounts 2019106,4 k €↑
  9. 2018
    Annual accounts 201828,1 k €↓
  10. 2017
    Annual accounts 201744,4 k €↑
  11. 2016
    Annual accounts 20161,7 k €↓
  12. 2015
    Annual accounts 201591,5 k €↑
  13. 2014
    Annual accounts 201459,8 k €↑
  14. 2013
    Annual accounts 201340,7 k €
  15. 30/01/2008
    IncorporationPrivate limited company